bosentan anhydrous has been researched along with Idiopathic Interstitial Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babalis, D; Birring, SS; Corris, PA; Corte, TJ; Dimopoulos, K; Elliot, CA; Foley, C; Gatzoulis, MA; Howard, L; Keir, GJ; Maher, TM; Marino, P; O'Reilly, K; Parfitt, L; Renzoni, EA; Spencer, L; Wells, AU; Wort, SJ; Yanez-Lopez, M | 1 |
| Carbone, RG; Nathan, SD | 1 |
1 trial(s) available for bosentan anhydrous and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bosentan; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension, Pulmonary; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Sulfonamides; Treatment Outcome; Vascular Resistance; Young Adult | 2014 |
1 other study(ies) available for bosentan anhydrous and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
Pulmonary hypertension due to fibrotic lung disease: hidden value in a neutral trial.
Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Idiopathic Interstitial Pneumonias; Male; Sulfonamides | 2014 |